Blair Williams Todt - 14 Dec 2023 Form 4 Insider Report for Elevance Health, Inc. (ELV)

Role: EVP, CLO & CAO
Signature: /s/ Kathleen S. Kiefer, Attorney in fact
Issuer symbol: ELV
Transactions as of: 14 Dec 2023
Net transactions value: -$947,590
Form type: 4
Filing time: 15 Dec 2023, 16:28:55 UTC
Previous filing: 05 Dec 2023
Next filing: 05 Jan 2024
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	ELV	Common Stock	Options Exercise	$1,710,648	+5,492	+44%	$311.48	18,004	14 Dec 2023	Direct
transaction	ELV	Common Stock	Sale	$2,658,238	-5,492	-31%	$484.02	12,512	14 Dec 2023	Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	ELV	Employee Stock Option (Right to Buy)	Options Exercise	$0	-5,492	-67%	$0.000000	2,746	14 Dec 2023	Common Stock	5,492	$311.48	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The option represents a right to purchase a total of 8,238 shares, and is exercisable in three annual installments of 2,746 shares each, beginning on 3/1/2022, which is the one-year anniversary of the option grant date.